Includes 1 agency outside the US.

Indication	Spread: box is the middle half, dot means most agree	Range
Agitation Adult		2 to 7.5 mg median 4.375, n=28
Pediatric, weight-based		0.1 to 0.2 mg/kg median 0.15, n=9
Nerve agent exposure Adult		2.5 to 10 mg median 7.5, n=13
Pediatric, weight-based		0.1 to 0.5 mg/kg median 0.2, n=8
Other Adult		2 to 10 mg median 3.75, n=40
Pediatric		Most use 1 mg range 1 to 2.5 mg, n=5
Pediatric, weight-based		0.1 to 0.3 mg/kg median 0.2, n=30
Procedural sedation Adult		2 to 5 mg median 5, n=30
Pediatric, weight-based		0.05 to 0.3 mg/kg median 0.1, n=14
Seizure Adult		2 to 10 mg median 5, n=63
Adult, weight-based		0.1 to 0.5 mg/kg median 0.2, n=5 median matches NASEMSO
Pediatric, weight-based		0.1 to 0.5 mg/kg median 0.2, n=64 median matches NASEMSO
Status epilepticus Adult		1 to 5 mg median 2.5, n=7
Pediatric, weight-based		0.15 to 0.2 mg/kg median 0.2, n=6

Too few protocols to chart yet (protocols in brackets): ACS / chest pain (2), Bradycardia (1), Dystonic reaction (1), Eclampsia / pre-eclampsia (3), Hyperactive delirium (5), Hyperthermia (2), Hypothermia (1), Nausea / vomiting (1), Organophosphate poisoning (5), Mild to moderate pain (3), Post-intubation sedation (5), RSI induction (4), SVT (1), Narrow-complex tachycardia (2), VF / pulseless VT (1)

Doses far off from what other protocols give are likely misreads, so they are left out until checked. How that works.